期刊文献+

通腑法治疗慢性阻塞性肺疾病呼吸衰竭的疗效观察 被引量:3

Effective observation on treating respiratory failure in patients with chronic obstructive pulmonary disease by the Tongfu therapy
下载PDF
导出
摘要 目的:观察对慢性阻塞性肺疾病呼吸衰竭行通腑法治疗的效果。方法:回顾性分析2014年5月-2015年5月本院收治的慢性阻塞性肺疾病呼吸衰竭110例患者的临床资料,按不同治疗方法分为两组(各55例),对照组行常规西医治疗,观察组在对照组的基础上行通腑法治疗,对比两组疗效与动脉血气指标改善情况。结果:观察组总有效率(96.36%)高于对照组的63.64%,差异有统计学意义(P<0.05)。结论:对慢性阻塞性肺疾病呼吸衰竭患者行通腑法治疗的效果显著。 Objective: To observe efficacy of the Tongfu therapy on respiratory failure in patients with chronic obstructive pulmonary disease. Methods: Clinical data of 110 cases in our hospital from May 2014 to May 2015 was retrospectively analyzed, and divided into two groups according to different treatment methods, 55 cases in each. The control group was given routine western medicine; the observation group was treated by the Tongfu therapy more. Efficacy and arterial blood gas improvement in two groups were compared. Results: The total efficiency in the observation group was 96.36%, and higher than 63.64% in the control group; the differences were statistically significant(P<0.05). Conclusion: The Tongfu therapy on respiratory failure in patients with chronicobstructive pulmonary disease shows a significant effect.
作者 彭平
机构地区 东平县中医院
出处 《中医临床研究》 2016年第14期68-70,共3页 Clinical Journal Of Chinese Medicine
关键词 慢性阻塞性肺疾病 通腑法 呼吸衰竭 效果 COPD The Tongfu therapy Respiratory failure Effects
  • 相关文献

参考文献5

二级参考文献38

  • 1杨娟,杨栓盈,倪磊,宋土生,于林,黄辰.慢性阻塞性肺疾病患者的血清差异表达蛋白分析[J].西安交通大学学报(医学版),2012,33(1):61-64. 被引量:1
  • 2慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华内科杂志,2007,46(3):254-261. 被引量:1790
  • 3张旻,周新,张杏怡,丁星.莫西沙星治疗慢性阻塞性肺疾病急性加重的近期和远期疗效观察[J].中国感染与化疗杂志,2007,7(5):313-317. 被引量:6
  • 4Falagas ME,Avgeri SG,Matthaiou DK,et al. Short ,versus long-dura- tion antimicrobial treatment for exacerbations of chronic: hronchitis.a meta-analysis [ J ]. J Antimicrob Chemother,2008,62 ( 3 ) :442 - 450.
  • 5Miravitlles M,Anzueto A. Moxifloxacin: a respiratory fluoroquinolo- ne[J]. Expert Opin Pharmacother,2008,9(10) :1755-1772.
  • 6Wilson R,Allegra L, Huehon G, et al. Short-term and long-term out- comes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis [ J ]. Chest, 2004, 125 (3) :953 -964.
  • 7Chuchalin A,Zakharova M, Dokic D, et al. Efficacy and safety of moxifloxacin in acute exacerbations of chronic bronchitis:a prospec-tire, multicenter, observational study (AVANTI)[J]. BMC Pulm Med,2013 ,13 :5.
  • 8Miravitlles M,Gierrero T, Mayordomo C,et al. Factors associated with increased risk of exacerbation and hospital admission in a co- hort of ambulatory COPD patients: a multiple logistic regression a- nalysis [ J ]. Respiration,2000,67 ( 5 ) :491.
  • 9Yoshikawa T, Kanazawa H. Association of plasma adiponectin lev- els with cellular hydration state measured using bioelectrical im- pedance analysis in patients with COPD [ J ]. Int J Chron Obstruct Pulmon Dis,2012,7:515 -21.
  • 10Gupta D, Agarwal R, Aggarwal A N, et al. Guidelines for diagno- sis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations[J]. Lung India,2013,30 (3) :228 -67.

共引文献104

同被引文献39

引证文献3

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部